The Prognostic Role of the Right Ventricle in Patients With Heart Failure or Congenital Heart Disease
Overview
The objectives are 1. to validate quantification of 2D and 3D right ventricular strian measurements of right ventricular performance in cross comparison to cardiac MRI and to evaluate its relation to right ventricular fibrosis. 2. to evaluate their prognostic value in patients with heart failure with either depressed or preserved ejection fraction.
Study Type
- Study Type: Interventional
- Study Design
- Allocation: N/A
- Intervention Model: Single Group Assignment
- Primary Purpose: Diagnostic
- Masking: None (Open Label)
- Study Primary Completion Date: September 30, 2020
Interventions
- Diagnostic Test: Medical imaging
- Medical Imaging consisting of 1 MRI and 1 echocardiography at baseline
Arms, Groups and Cohorts
- Experimental: Heart Failure Patients
- Patients with Heart Failure
Clinical Trial Outcome Measures
Primary Measures
- overall survival
- Time Frame: 3 years
Secondary Measures
- Heart Failure
- Time Frame: 3 years
- Hospitalization due to heart failure
Participating in This Clinical Trial
Inclusion Criteria
- Adult Patients with heart failure Exclusion Criteria:
- Renal failure – Contraindications to Cardiac MRI
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Collaborator
- Fonds National de la Recherche Scientifique
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Bernhard Gerber, MD,PhD, Principal Investigator, Cliniques universitaires Saint-Luc
- Overall Contact(s)
- Bernhard Gerber, MD,PhD, +3227642803, Bernhard.Gerber@uclouvain.be
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.